Sudarshan Chemical Industries Limited has informed the Exchange regarding Change in Director(s) of the company.
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical Industries' board, at its meeting on 23rd September 2025, approved unaudited financial results for Q1 FY26 (quarter ended 30th June 2025). Standalone revenue came in at ₹531.2 crore, down from ₹579.7 crore a year ago, but standalone profit after tax jumped to ₹73.3 crore from ₹41.1 crore, helped by a forex gain of ₹56.9 crore. Consolidated revenue surged to ₹2,506.9 crore from ₹633.6 crore, reflecting the Heubach pigment business acquisition completed in March 2025, with consolidated PAT at ₹55 crore. The board also appointed three new directors effective 1st October 2025: Mr. Apurva Chandra and Mr. Rajendra Mariwala as Non-Executive Independent Directors (5-year terms), and Mr. Amitabha Mukhopadhyay as Non-Executive Non-Independent Director. All appointments are subject to shareholder approval, and none of the new directors are related to existing directors or KMPs. Q1 results were delayed due to Heubach integration, and the company fully repaid its ₹99 crore NCDs in July 2025.
The three new independent and non-independent director additions strengthen the board ahead of shareholder vote, while strong consolidated growth signals successful integration of the Heubach acquisition, though standalone revenue decline and one-off forex gains warrant closer scrutiny by investors.